Cargando…

In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers

Background: Breast cancer is the most common type of cancer among women and is classified into multiple subtypes. Triple-negative breast cancer (TNBC) is the most aggressive subtype, with high mortality rates and limited treatment options such as chemotherapy and radiation. Due to the heterogeneity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaddoura, Rachid, Alqutami, Fatma, Asbaita, Mohamed, Hachim, Mahmood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965976/ https://www.ncbi.nlm.nih.gov/pubmed/36836779 http://dx.doi.org/10.3390/life13020422

Ejemplares similares

Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis
por: Kaddoura, Rachid, et al.
Publicado: (2023)

COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets
por: Alqutami, Fatma, et al.
Publicado: (2021)

Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas
por: Alqutami, Fatma, et al.
Publicado: (2023)

Using publicly available transcriptomic data to identify mechanistic and diagnostic biomarkers in azoospermia and overall male infertility
por: Omolaoye, Temidayo S., et al.
Publicado: (2022)

Toxicogenomic analysis of publicly available transcriptomic data can predict food, drugs, and chemical-induced asthma
por: Hachim, Mahmood Yaseen, et al.
Publicado: (2019)

The Role of Systems Biology in Deciphering Asthma Heterogeneity
por: Hachim, Mahmood Yaseen, et al.
Publicado: (2022)

Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women
por: Tabbal, Marah, et al.
Publicado: (2023)

Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy
por: López-Ozuna, Vanessa M., et al.
Publicado: (2016)

Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
por: Tian, Jun, et al.
Publicado: (2017)

Microbial Metabolic Genes Crucial for S. aureus Biofilms: An Insight From Re-analysis of Publicly Available Microarray Datasets
por: Nassar, Rania, et al.
Publicado: (2021)

Healthcare Derived Smart Watches and Mobile Phones are Contaminated Niches to Multidrug Resistant and Highly Virulent Microbes
por: Boucherabine, Syrine, et al.
Publicado: (2022)

Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers
por: Limsakul, Praopim, et al.
Publicado: (2023)

Large-scale in-silico identification of a tumor-specific antigen pool for targeted immunotherapy in triple-negative breast cancer
por: Kaufmann, Jessica, et al.
Publicado: (2019)

Metagenomic Sequencing and Reverse Transcriptase PCR Reveal That Mobile Phones and Environmental Surfaces Are Reservoirs of Multidrug-Resistant Superbugs and SARS-CoV-2
por: Boucherabine, Syrine, et al.
Publicado: (2022)

Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization
por: Al Qutami, Fatma, et al.
Publicado: (2023)

In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma
por: Almansoori, Asma, et al.
Publicado: (2022)

Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer
por: Chung, Jee Min, et al.
Publicado: (2018)

C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis
por: Hachim, Mahmood Y., et al.
Publicado: (2020)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Identification of RNA Virus–Derived RdRp Sequences in Publicly Available Transcriptomic Data Sets
por: Olendraite, Ingrida, et al.
Publicado: (2023)

Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer
por: López-Ozuna, Vanessa M., et al.
Publicado: (2021)

Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data
por: Shiraishi, Yuichi, et al.
Publicado: (2022)

Editorial: Biomarkers in Pulmonary Diseases
por: Mahboub, Bassam, et al.
Publicado: (2022)

Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
por: Zhai, Xiuming, et al.
Publicado: (2020)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

Protocol for stratification of triple-negative breast cancer patients using in silico signaling dynamics
por: Imoto, Hiroaki, et al.
Publicado: (2022)

Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages
por: Taminau, Jonatan, et al.
Publicado: (2012)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis
por: Chen, Chao, et al.
Publicado: (2022)

Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC)
por: Chuan, Tian, et al.
Publicado: (2020)

Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis
por: Zhong, Guansheng, et al.
Publicado: (2020)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer
por: Wang, Meng-Yuan, et al.
Publicado: (2021)

In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens
por: Parvizpour, Sepideh, et al.
Publicado: (2019)

Identification of FOXM1 as a specific marker for triple-negative breast cancer
por: Tan, Yanli, et al.
Publicado: (2018)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
por: Chen, Qingwang, et al.
Publicado: (2022)

The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient’s outcome: A single centered study
por: Hachim, Ibrahim Y., et al.
Publicado: (2021)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n9i414egee3gbkagdo6kmjt4en